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Abstract
Extracellular vesicles (EVs) are newly identified as cell-to-cell communication 
mediators that carry and transfer various regulatory molecules. Recent studies have 
shown that EVs play important roles in normal physiology and pathological condi-
tions of human reproduction. In the female reproductive system, EVs in follicular 
fluid, oviduct fluid, and uterine luminal fluid are considered as vehicles to regulate 
follicular development, oocyte maturation and mediate embryo–maternal crosstalk 
to affect embryo implantation and pregnancy. In the male reproductive system, 
prostasomes and epididymosomes are involved in regulating sperm maturation, 
motility, capacitation, acrosome reaction, and fertilization. EVs transmitted cargos 
also play important roles in reproduction-related pathologies, such as polycystic 
ovarian syndrome, endometriosis, pregnancy complications, male infertility, and 
gynecological malignant tumors. In view of the important roles in the reproduc-
tive system, EVs may be used as biomarkers or therapeutic targets for reproductive 
abnormalities and related diseases. In this chapter, we sorted EVs in human repro-
duction through their physical/pathological functions and mechanisms, and listed 
several EVs as biomarkers and clinical therapeutic applications in the future.
Keywords: extracellular vesicles, exosome, reproductive system,  
polycystic ovarian syndrome, endometriosis, pregnancy disorders, male infertility
1. Introduction
Cell communication is vital for all living organisms, whether between environ-
ment or host with single-celled organisms, or between cells in multicellular organisms 
[1]. As new-found mediators, extracellular vesicles (EVs) mediate a cell communica-
tion mechanism that is different from classic ways as long/short range of secretory 
signaling, receptor-dependent contact signaling, gap junction, etc. According to cell 
origin, biogenetic mechanisms, and physical features (size and density), EVs can be 
classified into three major categories: apoptotic body (ABs), microvesicles (MVs), 
and exosomes (EXOs) [2]. These vesicles act as shuttles, transporting “cargo” like 
protein, lipids, nucleic acids, and other regulatory chemicals from one tissue or cell 
to another through body fluid [3]. When EVs and their targets fuse, their cargos 
can influence the functioning of target cells, allowing them to engage in a variety of 
physiological and pathological processes. That is why EVs have a significant role in 
multiple biological processes and diseases, such as immune function, tissue homeo-
stasis, cancer, and neurodegenerative diseases. Recently, EVs have also been described 
in human female and male reproductive systems, including the oviduct, ovary, 
endometrium, embryo, prostate, and epididymis (Figure 1). EVs are key mediators 
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in human reproduction and take part in physiological processes like gametogenesis 
(spermatogenesis and oogenesis), fertilization (coordination of sperm capacita-
tion and acrosome reaction), embryogenesis, and implantation (crosstalk between 
mother and embryo). EVs and trigger and/or maintenance some conditions such as 
infertility, impotence, polycystic ovary syndrome (PCOS), endometriosis (EMs), 
premature ovarian failure (POF), and preeclampsia (toxemia) [2, 4].
2. EVs in the female reproductive system
The female reproductive system contains external and internal parts. Internal 
genital organs are mainly composed of the gonad (ovary), oviduct, and uterus 
(namely womb). As an organ whose basic functions are ovulation and the produc-
tion of hormones, ovary influences a woman’s feminine physical characteristics and 
affects the process of reproduction. In fertilization preparation, an ovulated oocyte 
enters the oviduct to meet spermatozoa (SPZ). Then fertilization occurs in oviduct 
when a sperm and an oocyte combine and fuse to form a zygote, which develops 
into a blastocyte and then implant uterus endometrium to further embryonic 
development. Finally, in the perinatal period, the fetus is delivered from the dilated 
cervix [5, 6]. Among these progresses, EVs coordinate the maturation of female 
gamete and mediate crosstalk to help successful embryo implantation (known as 
blastocyst implantation) and pregnancy in follicular fluid, oviduct, endometrium, 
vagina, semen, and embryo.
2.1 EVs derived from the ovary
The ovarian follicle is the basic unit of female ovary, which contains an oocyte 
that is surrounded by two-layer granulosa cells (GCs, including membrane/mural 
granulosa and cumulus granulosa), stromal cells (theca cells), and a liquid called 
follicular fluid (FF). FF offers a suitable micro-environment for follicle growth and 
oocyte development (oogenesis) in the ovary, so their relative stability of composi-
tion is indispensable. Similar to gap junctions between oocytes and somatic cells 
Figure 1. 
EVs from human reproductive systems.
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which mediated cell-to-cell communication, EVs in GCs, somatic cells, and FF 
mediate signal transmission and cell communication [7, 8], suggesting that EVs are 
carriers for molecular transfer in the ovary.
The first EVs in FF was reported in equine, which contains microRNAs (miR-
NAs) and proteins, and they could be taken by surrounding GCs in vitro and in 
vivo [9]. MiRNAs are involved in RNA silence as post-transcriptional regulators 
[10]. There are numerous miRNAs indirectly regulating follicular growth and 
oocyte maturation in human FF [7]: (1) miR-10b, miR-21-5p, miR-31, miR-95, 
miR-99b-3p, miR-134, miR-135b, miR-140-3p, and miR-190b participate in WNT 
signaling through glycoprotein signaling molecular WNTs potentially regulate 
follicle formation, growth, and ovulation/luteinization [11]. (2) miR-203, miR-218 
regulate MAPK (ERK1/2) pathway which activation is crucial for oocyte meiotic 
resumption, GCs proliferation and cumulus expansion [12]. (3) miR-489, miR-493, 
miR-503, miR-542-5p, miR-654-3p, miR-874, miR-886-5p, miR-887 as mediators of 
TGFβ. (4) miR-337-5p, miR-339-3p, miR-370, miR-449a, miR-455-5p, miR-483-5p 
as mediators of ErbB, etc. In addition, as we know, the expansion of cumulus-
oocyte complex (COC) is a key process of ovulation. A study showed that bovine 
FF EVs taken in cumulus could increase gene expression of cumulus expansion 
(PTGS2, PTX3, and TNFAIP6) and support the expansion process in vitro [13].
2.2 EVs derived from the oviduct
Oviduct is the place where occur oocyte transportation, fertilization, and 
initial embryo development. Oviductal extracellular vesicles (oEVs), as the main 
components of oviduct fluid, can orchestrate gamete/embryo-oviduct and embryo-
maternal interactions, hence supporting oocyte mature (in canine), embryonic 
development, and motility, capacitation, and fertilizing ability of sperm [14, 15]. 
The contents of oEVs (mRNAs, miRNAs, and proteins) are dynamic at different 
stages of the estrous cycle, suggesting that cargos of oEVs are under hormonal 
control [16]. The first oEVs in the oviductal fluid was described in mouse, and then 
they were identified in other mammals including human. In humans, oEVs (oviduc-
tosomes) arising from the apocrine pathway carry and deliver plasma membrane 
Ca2 + -ATPase (PMCA) which are fertility-modulating proteins. PMCA delivered to 
sperm can prevent premature capacitation and maintain Ca2 + levels homeostasis; 
lack of PMCA leads to sperm motility loss and male infertility in mice [17]. Bovine 
oEVs can pass through the zona pellucida and then be internalized by embryonic 
cells to increase blastocyst rate and improve the quality of embryo. The possible 
mechanism may involve: (1) The proteins of bovine oEVs involved in cell com-
munication, cell metabolism, localization, and reproduction [18]; (2) The miRNAs 
of bovine oEVs contribute to a successful pregnancy through inducing changes of 
embryonic transcriptome [15]; (3) Exosomes derived from bovine oviduct epithe-
lial cells (BOECs) improve the mitochondrial health of bovine embryo because they 
re-establish the tricarboxylic acid cycle (TCA-cycle) flux [19].
2.3 EVs derived from the endometrium
Successful pregnancy not only needs intercommunication in ovary and oviduct, 
but also the crosstalk between endometrium and blastocyst especially the tro-
phoblasts. Indeed, several studies have found that the secretions in endometrium 
affect the embryo. The first reported EVs of the female reproductive system are 
endometrium EVs (endEVs) in mouse uterine cavity [20]. EndEVs were found in 
endometrial fluid during the menstrual/estrous cycle, and were also released from 
endometrial epithelial cells cultured in vitro [21]. Several studies reported that the 
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EVs in the endometrium have autocrine/paracrine effects on regulation of receptiv-
ity and implantation of uterine [22].
In EndEVs of primary endometrial epithelial cells (ECCs), 35% of the proteins 
had not been reported before, indicating that the contents of EndEVs are unique 
[23]. EndEVs influence blastocyst implantation through their hormone-specific 
protein cargos to modulate trophoblast capacity of adhesion, migration, inva-
sion, and so on. Among these protein cargos, metalloproteinases (MMP-14 and 
ADAM10) regulated by the endometrial receptivity-related hormone are essential 
to trophoblast invasion and pregnancy outcome because they regulate (activate 
and degrade) other factors in endEVs. In vitro, when EndEVs are internalized by 
trophoblast cells, they can activate Focal Adhesion Kinase (FAK) signaling, thereby 
enhance the adhesive capacity of trophoblast cells [24–26]. The proteins of bovine 
endEVs in ECCs change during the peri-implantation period: endEVs enhance the 
expression of cell apoptosis genes in the preimplantation stage, but cell adhesion 
genes in the post-implantation stage [27].
MiRNAs of EndEVs act as modifiers for implantation. EndEVs contain specific 
miRNAs cargo which targets predictably genes involved in blastocyst implanta-
tion and crucial signaling pathways such as the VEGF, the Jak–STAT, and the 
Toll-like receptor in primary ECC and ECC1 (an endometrial epithelial cell line) 
[21]. During the window of implantation (the period allows blastocyte invasion), 
maternal miRNAs are differently expressed in human EndEVs. One of the miRNAs, 
miR-30d upregulates Itgb3, Itga7, and Cdh5, which are involved in embryo adhe-
sion in murine; treating miR-30d in vitro to murine embryo can increase embryo 
adhesion [28].
Sperm adhesion molecule 1(SPAM1)/PH-20 is a hyaluronidase which enhances 
sperm fertility. EVs in murine uterine luminal fluid can deliver SPAM1 to sperm 
membranes to increase sperm penetration through cumulus cell layers around 
oocyte, and adhesive to zona pellucida, same as SPAM1 transferred from epididymo-
some to SPZ play a significant role in sperm maturation and motility [2, 20]. While 
as mentioned earlier, in oEVs SPAM1 interaction with sperm to inhibit premature 
acrosomal reaction, showing that the EVs with the same cargo in different organs 
have multiple functions [17].
2.4 EVs derived from the placenta and embryo
Pregnancy is a unique immunomodulatory state in which the maternal immune 
system temporarily tolerates the paternal antigen so as to protect the fetus from 
allogeneic rejection, at the same time maintaining immune surveillance to protect 
the mother from external pathogens. EVs have been identified in trophoblastic cells, 
placenta, and maternal circulation [22]. Maternal immune response is effected by 
the EVs from endometrium, embryo, and trophoblast cells in early pregnancy, while 
by the EVs from the human placenta in late pregnancy [29].
Placenta is an important organ and performs a variety of functions to support 
pregnancy. Placental-derived EVs are important media for intercellular communica-
tion, considered to be potential mediators in regulating maternal immune response 
to achieve a successful pregnancy and maternal and infant health outcomes [30]. 
These EVs inhibit the immune response to the developing fetus and establish and 
maintain a systemic inflammatory response against infectious invaders [31]. The 
underlying mechanisms include: (1) Compared with non-pregnancy, during preg-
nancy, the cytokines such as transforming growth factor-β 1 and IL-10 increase, and 
the ability to induce caspase-3 activity in cytotoxic natural killer (NK) cells enhance 
in peripheral blood EVs, which promoting immunosuppressive phenotype by induc-
ing apoptosis to help regulate the maternal immune response to the fetus [32].  
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(2) In amnion (the innermost layer of placenta), miR-21 helps in embryo growth; 
histone 3 (H3), heat shock protein 70 (HSP70), activated form of prosenescenceP-
p38, MAPK participate in stress response and are related to pregnancy out-
come [33].
In addition to the placenta, embryos can also secrete EVs (embryo extracellular 
vesicle, eEVs) to participate in the regulation of implantation and other pregnancy 
processes. Embryos transferred to uterine are known as blastocyst, which consists 
of a fluid-filled cavity, inner cell mass (ICM), and trophectoderm/trophoblast (T) 
cells. Mouse embryonic stem cells from the ICM can produce MVs which reach the 
trophoblast ectoderm, thereupon enhancing the migration ability of trophoblast 
cells, both as isolated cells and in the whole embryo. Laminin and fibronectin 
exist in the eEVs of ICM orchestrate ICM to attach to the integrin on the surface 
of trophoblast cells and stimulates the cascade of c-Jun N-terminal kinase and 
FAK, increasing the migration of trophoblast cells. Injecting these eEVs into the 
blastocyst cavity of day 3.5 blastocysts can improve successful implantation rate 
[34]. EEVs-derived PIBF alters the maternal immune system by increasing IL-3, 
IL-4, and IL-10 to achieve a Th2-dominant cytokine balance. The aberrant expres-
sions of PIBF may lead to pregnancy failure [35]. In eEVs of trophoblast also carry 
a variety of factors regulating maternal immunity to protect the fetus, including: 
tissue factors (TFs), soluble vascular endothelial growth factor receptor1 (sFlt-1), 
immunosuppressive factors, and so on [33].
3. EVs in the male reproductive system
The male reproductive system consists of internal organs - gonads (testis), 
reproductive ducts (epididymis, vas deferens, ejaculatory ducts, male urethra), and 
accessory glands (seminal vesicle, prostate, urethral bulbar gland) and external 
organs. Testes produce sperm and secrete male sex hormones. SPZ/sperm produced 
by the testis are first stored in the epididymis; during ejaculation, SPZ are excreted 
through the vas deferens, ejaculatory ducts, and urethra. Semen is the protect fluid 
around SPZ containing seminal plasma (SP), which is derived from testis (5%), 
epididymis and prostate (20%), seminal vesicles (65%), and seminal vesicles 
(65%). Seminal plasma lipids and/or EVs are rich in lipids, sugars, growth factors, 
TF and proteins, which play important roles in sperm survival, membrane integrity, 
maturation, motility, capacitation, acrosome reaction, and immune surveillance 
regulation [2, 33, 36]. Seminal plasma extracellular vesicles (Seminal plasma EVs, 
spEVs) are mainly derived from epididymis and prostate in the male reproduc-
tive tract, and a large number of them exist in the seminal plasma. Proteins in the 
seminal plasma are provided by spEVs [37]. According to the source, there are two 
main types of spEVs: prostasomes and epididymosomes. A proteomic analysis 
showed that there are a total of 1474 proteins in seminal plasma-derived exosomes; 
bioinformatics analysis revealed that these proteins are involved in a variety of 
biological processes, such as cell growth and maintenance, metabolism, transport, 
energy pathways, and so on [38]. Human semen exosomes also contain a unique 
non-coding small RNA library, which may have a potential regulatory function to 
mediate fertilization by transmitting regulatory signals to the receptors to regulate 
the female reproductive tract [39].
3.1 EVs derived from the prostate
The first EVs of the reproductive system found in humans are prostasomes, 
which were observed in human prostatic fluid and seminal plasma in 1978 [40]. 
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Prostasomes are exosomes with a diameter of 30–500 nm, which are released from 
prostatic epithelial cells and are then transferred to the prostate duct. Prostasomes 
are characterized by a cholesterol-to-phospholipid ratio of 2:1, of which nearly 50% 
phospholipid is sphingomyelin, making its bilayer or multilayer lipoprotein plasma 
membrane very hard. This unique prostate membrane component allows the pros-
tate to fuse with and transfer its contents to other cells [41, 42]. Prostasomes can 
transport substances such as sphingomyelin, cholesterol, and saturated glycolipids 
to sperm to reduce their membrane fluidity in order to prevent premature or spon-
taneous acrosome reaction and premature capacitation [43]. Previous studies have 
shown that prostasomes may inhibit capacitation and acrosome reaction mainly 
through cholesterol transfer [44, 45]. Once the appropriate time for acrosome reac-
tion occurs, prostasomes also play important roles in the capacitation and induction 
of acrosome reactions as mediators of signal transmission to regulate the tyrosine 
phosphorylation pattern, which is necessary for sperm-oocyte interaction [46].
Sperm motility is affected by intracellular pH and 2Ca +  concentration. Prostasomes 
were determined to be associated with 2Mg +  and 2Ca + dependent ATPase activity 
when they were first identified, suggesting that they are related to sperm energy 
metabolism [47]. Annexins of prostasome can activate 2Ca +  channel and increase the 
level of 2Ca + in sperm through carrying CD38 and RyR to sperm to stimulate the 
production of cyclic adenylate diphosphate, thus affecting sperm motility. After 
ejaculation, prostasomes interact with sperm and protect them from female reproduc-
tive tract acidic environment and regulate sperm motility through PH- dependent 
manner to maintain the ability of sperm fertilization and prepare for an encounter 
with oocytes [48, 49]. Prostasomes transfer proteins (such as galactose lectin 3 and 
CD48) can protect sperm from immune reaction by regulating immune response 
pathways, such as inhibition of complement pathway, lymphocyte proliferation, and 
phagocytosis of monocytes and neutrophils in the female reproductive tract [50].
Additionally, prostasomes have antioxidant properties. By interacting with poly-
morphonuclear neutrophils that produce ROS, prostasomes can reduce the produc-
tion of ROS, protect sperm and improve sperm survival rate. Prostasomes also carry 
aminopeptidase N, a protein involved in regulating sperm motility which acts by 
regulating endogenous opioid peptides (such as enkephalin) [51, 52]. Prostasomes 
are known to contain a variety of coding and non-coding regulatory RNAs with 
potential regulatory functions [39]. Currently, there are few studies on nucleic acid 
cargos of prostasomes and their effects on the male reproductive system.
3.2 EVs derived from the epididymis
Epididymosomes are produced by epididymal epithelial cells through apocrine 
secretion. They are a kind of exosomes with a diameter of 50–250 nm and character-
ized by high cholesterol/phospholipid ratio. Epididymosomes were first found in the 
intraluminal compartment of the epididymis of Chinese hamsters, and then in mice, 
rats, cattle, sheep, and humans. Epididymosomes can carry and transport numer-
ous proteins with biological functions (including enzymes, adhesion molecules, 
transport, and signal transduction proteins) and non-coding RNA (such as miRNA). 
These proteins and non-coding RNA play an important biological role in the process 
of sperm maturation and fertilization, participating in the acquisition of motility, the 
acquisition of fertilization ability, and protection against oxidative stress [50, 53–55].
The proteins of epididymosomes including aldo-keto reductase family 1 member 
B (AKR1B1), phosphatidylethanolamine binding protein 1 (PEBP1), macrophage 
migration inhibitory factor (MIF), polyol pathway enzymes, glutathione peroxidase 
5 (GPX5), plasma membrane 2Ca + -ATPase 4a (PMCA4), ubiquitin, and SPAM1/
PH-20. AKR1B1 and PEBP1 can jointly regulate the sperm state, keeping sperm at a 
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quiescent state during transportation until ejaculation [56]. MIF and polyol pathway 
enzymes are involved in sperm maturation and fertilization. GPX5, together with 
ubiquitin, is transferred to the sperm acrosome region during sperm epididymal 
transport, which protects sperm from oxidative stress, maintains the integrity of 
DNA, and prevents premature acrosome reaction. As a calcium efflux pump, PMCA4 
carried by epididymosomes can regulate calcium concentration, affect the activation 
of calcium signaling pathway and maintain the homeostasis of 2Ca +  in spermatozoa. 
Sperm delete PMCA4 leads to loss of hyperactivation and capacitation. GPI anchor-
ing proteins include P34h and SPAM1/PH-20. As mentioned earlier, they are sperm 
binding proteins related to epididymosomes, which locate on the sperm surface 
during sperm epididymal transport, mediating the docking between epididymo-
somes and sperm and providing a “highway” for epididymosomes to transport their 
cargos to participate in the process of fertilization. Similar to their function are the 
P25b/P26 that facilitate sperm binding to the zona pellucida [33, 57–61].
Epididymosomes are also mediator of cell communication. New surface antigens 
are obtained on the sperm surface during epididymal transport, which are related 
to the acquisition of fertilization ability. Epididymosomes transmit Notch signals 
between epididymal epithelial cells and between epididymis and SPZ to influence 
sperm motility [62].
Epididymosomes are also rich in non-coding RNA. Epididymosomes contain 
many kinds of miRNA, such as miR-888, miR-182, miR-24, and miR-15b. MiR-888 
of epididymosomes maintains sperm flagella peristalsis and mature sperm structure 
by regulating SPAG6 and SPAG1. Target gene prediction shows that miR-15b can 
specifically regulate the expression of IDH3A and control energy metabolism in TCA 
cycle, while miR-182 and miR-24 can specifically regulate the expression of glyco-
gen synthase kinase 3α (GSK3A), and phosphorylation of GSK3A can affect sperm 
motility. Functional enrichment analysis shows that these miRNAs play important 
roles in embryonic development. There are also inflammation-related miRNAs in 
epididymosomes, such as miR-181a and miR-1224. Studies have shown that miR-
181a participates in inflammatory response by regulating B cell differentiation and T 
cell receptor signals. MiR-146 can inhibit inflammation and innate immune response 
by down-regulating various pro-inflammatory cytokines, but its specific mechanism 
needs to be further studied. When inflammation exists, miR-1224 activates the 
immune response by down-regulating the expression of TNF- α. Epididymosomes 
also contain miR-29a, which enhances the expression of nuclear autoantigen sperm 
protein (NASP) and inhibits the proliferation of epididymal epithelial cells [63–68].
In addition, epididymosomes contain a small molecule: tRNA-derived small 
RNAs (tsRNA). Studies have shown that tsRNAs have the functions of regulating 
gene transcription, cell proliferation and apoptosis, and stress response [69, 70].
4. Implications of EVs in reproductive pathology
4.1 Polycystic ovarian syndrome
Polycystic ovary syndrome (PCOS) is one of the most common reproductive 
endocrine diseases in women of childbearing age (global prevalence rate: 4–21%). The 
clinical features of PCOS are: hyperandrogenemia, polycystic ovary (PCO) morphol-
ogy, and oligo-ovulation/anovulation [71]. PCOS as a disease of follicular abnormal, 
there is a close relationship between EVs in follicles and the pathogenesis of PCOS [72].
The amount of EVs (mainly exosomes) in plasma of patients with PCOS are 
significantly increased and positively correlated with the number of follicles [73]. 
The expression of non-coding RNAs altered in exosomes of FF in PCOS, including 
Extracellular Vesicles
8
miRNAs, piRNAs, and tRNAs [74]. Further study found that there is differential 
expression of miRNAs in plasma exosomes of women with PCOS, which was related 
to the menstrual cycle, antral follicle count (AFC, means the number of antral 
follicle) and hormone levels [75]. LncRNAs and circRNAs are also differentially 
expressed in follicular exocrine bodies of patients with PCOS. They may regulate 
ovarian steroid production, aldosterone synthesis, and secretion, and involved 
in Jak–STAT signal pathway, hippo signal pathway, and MAPK signal pathway. A 
high-throughput lncRNAs sequencing study found that there are 1253 upregu-
lated and 613 down-regulated lncRNAs in FF exosomes of patients with PCOS 
infertility compared with patients with non-PCOS infertility, and nine lncRNAs 
with significant changes may play an important role in the pathogenesis of PCOS 
(lncRNA-LINC00173, lncRNA-H19, lncRNA-HDAC6, lncRNA-POP4, lncRNA-
PTEN, lncRNAAKT3, lncRNA-DICER1, lncRNA-NF1, and lncRNA-MUM1). High-
throughput sequencing of circRNAs also found the expression of 167 circRNAs in 
FF exosomes of PCOS patients are significantly upregulated and 245 circRNAs are 
significantly down-regulated compared with the control group, suggesting that 
these abnormally expressed circRNAs may play some roles in the study of patho-
physiological mechanism of PCOS [76–78]. Similarly, proteins in exosomes of FF 
also changed. A proteomic study of exosomes from FF in patients with PCOS and 
healthy controls found that exosomes rich in S100-A9 can activate NF-κB signaling 
pathway in GCs and may play key roles in the progression of PCOS [79].
4.2 Endometriosis
Endometriosis (EMs) is an estrogen-dependent inflammatory disease, charac-
terized by the deposition and growth of endometrial stromal cells (ESCs) outside 
the uterine cavity, resulting in the appearance of endometrial tissue with growth 
activity outside the uterine body. Pelvic peritoneum and ovary are the most 
common sites of ectopic endometrial stromal cells (EuESCs) growth. The main 
clinical manifestations are pelvic pain, pelvic adhesion, infertility and so on. EMs 
affects millions of women around the world, and the cause remains to be further 
determined [80].
The number of EVs in cervical and vaginal samples of rhesus monkeys with 
EMs decreased, indicating that the synthesis pathway of EVs in EMs has changed 
[81]. EMs are closely related to the formation of blood vessels. The biologically 
functional exosomes released by ESCs are transported to other parts through blood 
countercurrent in the endometrial and peritoneal microenvironment, and mediate 
intracellular signal transduction to ESCs itself or neighboring cells through the 
intercellular space in an autocrine or paracrine manner, thus regulating angio-
genesis. In vitro, exosomes mediate the promotion of angiogenesis by EuESCs in 
the development of EMs [82]. Previous studies have shown that miRNAs can be 
extracted from the exosomes of ESCs, and these miRNAs potentially regulate the 
angiogenesis of ESCs. The expression of miRNA-21 related to angiogenesis in the 
exosomes of women with EMs is significantly higher than that of women without 
Ems [83]. Our research group identified the differential expression patterns of 
exosomal miRNAs in patients with EMs and found that 49 miRNAs expressed 
differentially in EuESC exosomes compared with normal endometrial stromal cells 
(NESCs) exosomes. Many exosomal miRNAs may be involved in regulating endo-
metrial receptivity in women with EMs-related infertility through their predicted 
target genes: homeobox A10 (HOXA10) and leukemia inhibitory factor (LIF) 
which are essential for normal implantation. Our finding provides a new sight on 
how EVs participate in the occurrence and development of EMs [84].
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4.3 Pregnancy complications
Common pregnancy complications include gestational hypertension, diabetes, 
and preeclampsia. Serious pregnancy complications may endanger the lives of 
fetuses and mothers [85]. The concentration and biological activity of EVs changed 
in a variety of pregnancy complications, such as preeclampsia (PE), gestational 
diabetes mellitus (GDM), preterm delivery (PTB), intrauterine growth restriction 
(IUGR), recurrent abortion and unexplained abortion, suggesting that EVs are 
closely related to pregnancy complications [86, 87].
Maternal obesity is a risk factor for GDM and several other pregnancy 
complications. Adipose tissue hypertrophy or metabolic stress can change the 
cargos in EVs (mainly miRNAs), leading to systemic inflammation and insulin 
resistance (IR) in obese patients with gestational diabetes. These altered EVs may 
also change the physiological function of placenta and remove the regulation 
of placental nutrition signal pathway, resulting in obesity-related pregnancy 
complications [88–90].
There is a class of syncytial nuclear aggregates (SNAs) in placental-derived 
EVs the level of which increases with the progression of pregnancy and is associ-
ated with pregnancy complications such as PE [91]. Numerous placental EVs were 
detected in the serum of pregnant women with PE. These EVs have pro-inflamma-
tory, anti-angiogenic, and procoagulant activities, which may lead to activation 
of the blood coagulation system, systemic inflammation, and vascular endothelial 
dysfunction [92]. In addition, the abundance of syncytin-2 in serum-derived EVs 
attenuates in women with PE. This may lead to immunosuppressive reduction and 
pathological inflammation in pregnancy complications [93].
4.4 Male infertility
Infertility has becoming a global health problem, the incidence rate is as high 
as 15%, of which about 50% of infertility cases are caused by male reproductive 
disorders [94]. Just as oocytes need normal FF microenvironment to provide 
nutrition and support, sperm also need SP to provide a safe environment in order 
to survive and transport in the female reproductive tract. As mentioned earlier, 
there are a train of semen proteins in SP, most of which are transported by EVs 
(prostasomes and epididymosomes). Since only EVs proteins from normal sperm 
can regulate the movement of SPZ and trigger SPZ capacitation, the changes 
of proteomic characteristics in semen EVs may indicate male reproductive tract 
dysfunction; at the same time, they can be used as a biomarker of male infertil-
ity. In male infertility, the proteins transported by reproduction-related EVs 
are differentially expressed in azoospermia, asthenospermia, oligozoospermia, 
teratospermia, or other male infertility compared with normal sperm, and the 
prostatic proteins related to sperm energy production and sperm activity are 
under expressed in abnormal sperm, indicating that SP proteome map may be a 
potential indicator of sperm dysfunction [36].
Azoospermia may be one of the causes of male infertility. There are two types 
of azoospermia: non-obstructive (NOA) and obstructive azoospermia (OA) caused 
by seminal tract obstruction [95]. A study found that deficiency of EVs contrib-
utes to lower ejection volume, and changes of various nutritional components in 
semen [96].
At present, a sea of EV cargos has been identified to be differentially expressed 
in male infertility patients, which can be used as diagnostic markers and treatment 
of infertility as detailed in the next section.
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4.5 Ovarian and cervical cancer
Gynecological malignant tumors such as ovarian cancer (OC) and cervical 
cancer (CC) are two of the three major tumors of the female reproductive system, 
the former with the highest mortality rate and the latter with the second incidence 
and the third fatality rate [97, 98]. The difficulty of early diagnosis, high metastasis 
rate, and strong drug resistance are still the main obstacles in gynecological cancer 
diagnosis and treatment. As a member of tumor microenvironment, exosomes not 
only play important roles in tumor occurrence and development, drug resistance 
and immunosuppression, but also can be used as a new tumor marker and clinical 
target molecule in clinical work.
The latest study has proved that there is a difference in the expression of exo-
somes in the blood of patients with OC and normal people, and the expression 
in the body fluid of patients with OC is related to the stage of the tumor [99]. A 
total of 1017 co-expressed proteins were screened from the exosomes secreted by 
two kinds of OC cells, among which tubulin beta 3 class III (TUBB3), epithelial 
cell adhesion molecule (EpCAM), claudin 3 (CLDN3), proliferating cell nuclear 
antigen (PCNA), epidermal growth factor receptor (EGFR), and fatty acid syn-
thase (FASN) were highly enriched in tumor-related signal pathways. Claudin-4 
positive exosomes can be used in the diagnosis of OC, with a specificity of 98% 
and a sensitivity of 51%, while CA125 has a specificity of 98% and a sensitivity of 
71%. Although claudin-4 is not a better diagnostic marker than CA125, this study 
confirms that exosome-related proteins can be used in the diagnosis of OC. These 
results suggested that the related proteins in exosomes may become markers for the 
diagnosis of OC [100, 101]. In addition, the level of exosomal proteins extracted 
from the serum of patients with OC were higher than that of patients with benign 
ovarian disease and healthy women, and that of patients with advanced OC was 
higher than that of patients with early stage. The expression of tumor-specific 
antigen MAGE3/6 and transforming growth factor β1 (TGF- β1) in patients with 
OC was significantly higher than that in patients with benign ovarian disease and 
healthy women [102]. CD24 is a marker of poor prognosis in OC and other types 
of cancer. CD24 positive exosomes were screened from ascites of patients with OC, 
which is a good marker for early diagnosis of OC [103].
There are a large number of exosomes in cervicovaginal lavage specimens of 
women with CC, which carry miRNAs playing important roles in CC. It was found 
that many differentially expressed miRNAs, such as miR-483-5p, miR-1246, miR-
1275, microRNA-21, microRNA-146a and miR-222-3p, were up-regulated in vaginal 
lavage and cell culture of CC, while some miRNAs, such as let-7d-5p, miR-92a-3p, 
miR-20a-5p, miR-378a-3p, miR-423-3p, miR-7-5p, miR-99-5p, miR-100 5p and 
miR-320a, were down-regulated. It is suggested that the contents of miRNAs in 
exosomes may be related to the occurrence of CC and is expected to become a new 
diagnostic marker of CC [104]. There was a significant difference in the expres-
sion of exosome-mediated let-7d-3p and miR-30d-5p between cervical tumors and 
adjacent normal tissues, suggesting that these two plasma exosomes let-7d-3p and 
miR-30d-5p can be used as valuable biomarkers for non-invasive screening of CC 
[105]. The exosomes of cervical squamous cell carcinoma (CSCC) transfers miR-
221-3p from cancer cells to vascular endothelial cells and promote angiogenesis by 
down-regulating thrombospondin-2 (THBS2) [106]. In addition, exosomal miR-
221-3p secreted by CC cells promotes the invasion, migration, and angiogenesis of 
CC microvascular endothelial cells (MVECs) by down-regulating the expression of 
MAPK10 [107]. The expression of activating transcription factor 1 (ATF1) and RAS 
genes were significantly upregulated in primary and recurrent CC mouse models, 
and ATF1 and RAS could also be detected in blood exosomes of mouse models. 
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These results suggest that exosome-mediated ATF1 and RAS may become potential 
diagnostic markers for CC, which provides a new idea for individual detection and 
treatment of CC [108].
5. Clinical and therapeutic applications of EVs in reproductive disorders
5.1 EVs as biomarkers
The optimal age to have a baby is a medical social problem that needs to be faced 
by the whole society. Based on the risk of fetal disease, male and female fertility, and 
many other factors, it is generally believed that the best childbearing age for men and 
women is between 25 and 35 years old. With the increase of age, the semen quality 
of men decreases, the sperm concentration and motility decrease, and the deformity 
rate increases; the quality of oocytes decreases in women, which limits the success of 
pregnancy [109]. Therefore, looking for reproductive-related markers that change 
with age has become a meaningful research direction. It is found that the miRNAs 
characteristics of follicular EVs vary with the age of women, suggesting that miRNAs 
of EVs are possible markers and predictors of age-related oocyte quality decline [9]. A 
study compared the EVs of FF in young women with that in older women and found 
four significantly different miRNAs: miR-99b, miR-134, and miR-190b were upregu-
lated, and miR-21-5p was down-regulated in older women. These miRNAs regulate 
genes related to cell apoptosis, p53 signaling, and cytokine-cytokine-receptor interac-
tion, so their changes may affect follicular development and oocyte maturation [110].
There are numerous EVs in SP which can easily detach and collection. A study 
identified that prostasomal proteins relating to sperm activity and energy pro-
duction pathways have changed in non-normozoospermic men. Among them, 
HIST1H2B, KLK2, MIF, MPO, and MSMB are related to liquefaction of semen (in 
order to break through SP) and sperm-oocyte binding. LDHC, HK1, PNP, APRT, 
and SLC2A14 are involved in sperm energy production [111]. Others include 
ELSPBP1/BLVRA, GPX5, SPAM1, P34H, Aldose reductase and sorbitol dehydroge-
nase, PAP, PSA, TMPRSS2, pTGase, PSCA, KIF5B, ANXA2, and so on [50]. Due to 
these variations may have a relevant correlation with male infertility, the cargos of 
EVs can potentially serve as useful biomarkers of male infertility.
In ART, FF can be taken out together with the follicles, so it is an attractive 
biomarker to detect the quality of oocytes. The expression of miRNAs in EVs is 
related to fertilization status and embryo quality [112]. It has been found that the 
overexpression of miR-92a and miR-130b can lead to adverse results of in vitro 
fertilization (IVF), while the differential expression of miR-214, miR-454, and 
miR-888 is related to high quality embryos [113].
Peripheral blood is the most widely used biological sample in clinical diagnosis. 
The cargos in EVs in peripheral blood are good indexes for the detection of many 
diseases [114]. Prostasomes produced by prostate tumor cells may be involved in 
the spread of prostate cancer. Prostate corpuscles in peripheral plasma and their 
specific proteins, such as PAP, PSA, TMPRSS2, and PSCA, may be valuable bio-
markers of prostate cancer [115]. Since EVs and their content in women’s peripheral 
blood can be detected from early pregnancy, they can be used as biomarkers for the 
prediction or diagnosis of pregnancy complications, fetal developmental disor-
ders, and preterm birth (PTB). About 11% of infants around the world are born 
prematurely every year. PTB, defined as delivery before 37 weeks of pregnancy, 
is the leading cause of neonatal morbidity and mortality. The exosomes in plasma 
can be used to predict whether pregnant women will develop PTB, so as to prepare 
for prenatal intervention. Several miRNAs such as hsa-miR-381, hsa-miR-154, 
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hsa-miR-377, and hsa-miR-150-5p in circulating EVs have been predicted to be 
potential biomarkers of PTB. A longitudinal study analyzed the miRNAs in plasma 
EVs collected from multiple pregnant women throughout pregnancy and found that 
the number and expression profile of miRNAs of EVs in maternal plasma of PTB 
changed significantly compared with the term birth, especially these miRNAs asso-
ciated with TGF-β, p53, and glucocorticoid receptor signaling. It is worth pointing 
out that these miRNAs are known to be associated with fetal membrane apoptosis 
[116–119]. Fetal cell-free DNA (cfDNA) carried by maternal circulating plasma and 
serum exocrine has been used in non-invasive prenatal diagnosis as a biomarker of 
pregnancy complications, such as PE and GDM [120].
MVs from vaginal microbes (e.g., Group B Streptococcus) can affect fetal 
placental tissue and lead to pregnancy complications [121]. Therefore, it may be 
possible to detect the contents of vaginal MVs to find significantly differential 
cargos, so as to detect pregnancy complications as soon as possible.
With the deepening of research, studies in mounting numbers have shown that 
the miRNAs in EVs can be used to diagnose pregnancy-related diseases, including 
miR-136, miR-155, miR-210, miR-486, miR-494, miR-495, miR-517-5p, miR-
520a-5p, miR-525-5p, and miR-548c-5p [122].
Wrong or late diagnosis is one of the main problems of EMs. Therefore, it is of 
great significance to find biomarkers for early diagnosis. Extracellular nucleases are 
key enzymes in the process of inflammation, which participate in the occurrence 
and development of EMs by regulating the levels of extracellular ATP and adenos-
ine. A study has found that the extracellular nuclease activity in the aspiration fluid 
of endometrial tumors is significantly higher than that of simple cysts and comes 
from the exosomes of these fluids, and therefore the exosomes of these lesions may 
become biomarkers of EMs. The proteins and miRNAs transported by endEVs may 
be very valuable biomarkers of human endometrial diseases [123].
The expression of DENN domain containing 1A (DENND1A) in urine-derived 
exosomes of PCOS patients was significantly higher than that of normal controls, 
suggesting that it can be used as a potential PCOS marker [124].
5.2 Clinical and therapeutic applications
As biological substances are produced by normal human bodies, the in-depth 
study of EVs in different physiological and disease states is helpful to identify 
specific proteins related to EVs functional defects, thus promoting the development 
of new diagnoses and treatment strategies for reproductive dysfunction. EVs have 
attracted much attention in the field of translational medicine because compared 
with other commonly used synthetic drug delivery carriers (such as liposomes), 
bioengineered EVs have not only have inherent targeting ability but also are low 
immunogenicity, easy to obtain, selective assembly, high modification flexibility, 
and biological barrier permeability. Considering EVs can deliver functional cargos 
to target cells, it is hopeful for us to use them as a drug delivery tool. For example, 
EVs may be able to pass through the tissue barrier (such as endothelial barrier, 
blood–brain barrier, endothelial barrier, and blood–brain barrier) through endocy-
tosis. At present, the application of exosome therapy has been explored in a variety 
of reproductive diseases, such as the treatment of female infertility, POI, EMs, IUA, 
and so on. For instance, exosomes can carry specific miRNAs into receptor cells to 
target genes. There are also studies to target the treatment of related diseases by 
putting modified small interference RNA (siRNAs) into exosomes [125, 126].
EuESCs can secrete a large number of exosomes, which contain a variety of miR-
NAs may not only be closely related to the occurrence, development and complica-
tions of EMS, but also have different expression levels from normal endometrial 
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cells. Therefore, exosomal miRNAs have certain application value in the early 
diagnosis, judgment of disease progression, and prognosis of EMs. In EMs mouse 
models, the delivery of miR-214 rich exosomes isolated from EuESCs can inhibit 
fibrosis and regulate the development of EMs [127].
Exosomes derived from endometrial epithelial cells can enhance the adhesion, 
implantation, and growth ability of embryo in vivo [128]. EVs obtained by uterine 
lavage carries proteins that regulate and predict embryo implantation, and its 
protein composition, metastatic and invasive properties, and antioxidant function 
are dynamically regulated throughout the menstrual cycle, so it has the potential 
to be used as a biomarker of embryonic development, implantation, and successful 
pregnancy [129].
PCOS and GDM are closely related to obesity. Adipose tissue macrophages 
(ATM) of obese mice secrete exosomes containing miRNAs, which can lead to 
impaired glucose tolerance and IR when given to thin mice. In contrast, ATM 
exosomes obtained from lean mice can improve glucose tolerance and insulin sensi-
tivity when given to obese mice. These miRNAs can be transferred to insulin target 
cells through paracrine or endocrine regulation, and have a strong effect on cellular 
insulin action, insulin sensitivity, and global glucose homeostasis [88]. Therefore, 
the differentially expressed miRNAs of ATM in obese and thin people may be used 
as biomarkers of PCOS and GDM and used in their treatment.
Premature ovarian failure (POF) is defined as ovarian function lost in women 
before 40 years of age. The incidence of POF in women is about 1%. The occurrence 
of POF is closely related to the depletion of ovarian follicles, but the specific mecha-
nism is still not clear [130]. The combination of stem cell therapy and EVs provides 
a glimmer of hope for the treatment of POF. In one study, exosomes collected from 
Bone mesenchymal stem cells (BMSCs) were injected into POF mice, and then found 
that follicles, FF, and corpus luteum increased in mice ovaries, while apoptosis-related 
genes p53 and caspase3 were down-regulated, indicating that BMSC-derived exo-
somes can improve the phenotype of POF. Further in vitro experiments showed that 
the expression of miR-664-5p was increased in BMSC-derived exosomes and could 
reverse the injury of POF granulosa cells, which was regulated by p53 [131]. Another 
study found that miR-144-5p in BMSC-derived exosomes inhibit POF GCs apoptosis 
by targeting PTEN and activating the PI3K/AKT pathway in vitro [132]. Furthermore, 
exosomes derived from human amniotic epithelial cells (hAECs), amniotic fluid stem 
cells (AFSCs), and placenta-derived mesenchymal stem cells (PD-MSCs) can regu-
late the apoptosis pathway to reduce the apoptosis of ovarian follicles through their 
different cargos, such as miR-10a, miR-146a, miR-1246, and antioxidant enzymes 
[133]. Taken together, these studies demonstrated that exosomes can mediate ovarian 
function, thus pointing out a new direction for the treatment of POF.
6. Conclusions
Gametogenesis, fertilization, implantation and early embryonic development 
are complex processes that are highly dependent on communication between cells 
and organs. The transmission of EVs between cells as a newly discovered way 
of cell communication, is increasingly found to play crucial and multiple roles 
in the field of reproduction. In the male reproductive system, prostasomes and 
epididymosomes derived from prostate/epididymis are found in semen, which 
contribute to maturation, motility, activation, capacitation of SPZ and acrosome 
reaction (Figure 2). In the female reproductive system, the two-way communica-
tion between oocytes and somatic cells around them (companion somatic cells) 
is important for the development of oocytes fertilization and embryogenesis. 
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EVs in ovary, oviduct, endometrium and placenta are the carriers of information 
during gametogenesis, fertilization and embryo-maternal dialog, helping follicle 
and oocyte development and maturation. While in fertilization, they can regulate 
maternal immunity, promote early embryo development, assist implantation, and 
maintain pregnancy, which are all vital for successful pregnancy. In pathologies, 
EVs play important roles in female reproductive system disorders, such as PCOS, 
EMs, pregnancy complications (Figure 3).
In the process of EVs synthesis, different RNAs, proteins and other contents 
are selectively packaged into EVs, therefore the data of genomics, proteomics and 
metabolomics in EVs may be different between normal physiological state and 
conditions, and the number and composition of EVs may reflect the functional state 
of its cell origin. In view of the importance of this mode of intercellular commu-
nication in the reproductive system, EVs can be used as biomarkers or therapeutic 
targets for reproductive diseases in the field of reproductive system diseases and 
assisted reproductive technology (ART) (Table 1).
Figure 2. 
The functions of EVs in male reproductive system.
Figure 3. 
The functions of EVs in female reproductive physiology and pathology conditions.
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Sex Diseases EV cargos References
Female Polycystic ovary 
syndrome
LncRNAs: LINC00173, H19, HDAC6, POP4, 
PTEN, AKT3, DICER1, NF1 and MUM1
Protein: S100-A9
[76–78]
Endometriosis MiRNAs: miR-21, miR-615-3p, miR-6873-3p, 
miR-3195, miR-196a-5p, miR-4483, miR-




Proteins: TUBB3, EpCAM, CLDN3, PCNA, EGFR, 
FASN, MAGE3/6, TGF- β1, ATF1, RAS
MiRNAs: miR-483-5p, miR-1246, miR-1275, 
microRNA-21, microRNA-146a and miR-222-3p, 
let-7d-5p, miR-92a-3p, miR-20a-5p, miR-378a-3p, 
miR-423-3p, miR-7-5p, miR-99-5p, miR-100 




Male Male infertility Proteins: HIST1H2B, KLK2, MIF, MPO, MSMB, 
LDHC, HK1, PNP, APRT, SLC2A14
[111]
Table 1. 
Potential EVs biomarkers in different reproductive diseases.
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